Presentation TCT 2016 RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso November 02, 2016
Presentation TCT 2016 How to Treat BRS Restenosis (With Case Examples) Presenter: Ashok Seth, Pieter C. Smits November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice! Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller November 01, 2016
Presentation TCT 2016 TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the Nanoluté Registry Presenter: Germano Di Sciascio, Bruno Scheller November 01, 2016
Presentation TCT 2016 Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up Presenter: Fernando Alfonso, Ran Kornowski, Pieter R. Stella November 01, 2016
Presentation TCT 2016 Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results from the Nanolute Registry Presenter: Fernando Alfonso, Ran Kornowski, Bernardo Cortese November 01, 2016
News Conference News TCT 2016 New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts Yael L. Maxwell October 31, 2016
Presentation TCT 2016 Case Resolution: How Did We Treat this Patient? Presenter: Nick Curzen, Michael Mahmoudi October 31, 2016
Presentation TCT 2016 TAVR Restenosis: Review of the Literature Presenter: Nick Curzen October 31, 2016
Presentation TCT 2016 Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR Presenter: Nick Curzen, Michael Mahmoudi October 31, 2016
Presentation TCT 2016 TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo October 31, 2016
Presentation TCT 2016 TCT 44: Independent Mitral Valve Restenosis Predictors After Percutaneous Mitral Balloon Valvuloplasty in a Large, Consecutive Cohort Followed for More Than Two Decades Presenter: Stephan Baldus, Allan Schwartz, Alfredo Nunes Ferreira Neto October 31, 2016
News Industry News First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months October 31, 2016
News Conference News TCT 2016 ‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent Todd Neale October 31, 2016
Presentation TCT 2016 Case Presentation: Evaluation and Management of Recurrent DES Restenosis Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla October 30, 2016
Presentation TCT 2016 Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman October 30, 2016
Presentation TCT 2016 Prognosis and Treatment Options for DES Restenosis and Re-restenosis Presenter: Fernando Alfonso, Stephan Windecker October 30, 2016
Presentation TCT 2016 Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong October 30, 2016
Presentation TCT 2016 How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini October 30, 2016